Product Description
Favipiravir(6-Fluoro-3-hydroxypyrazine-2-carboxamide), a purine nucleic acid analog thathas been developed by Toyama Chemical in Japan for a treatment of viralinfections including influenza.3 This has recently been evaluated and was foundto be a promising choice in management of COVID-19. It works by inhibiting RNAdependent RNA polymerase (RdRp) enzyme, a key enzyme impeding replication ofRNA viruses.
Quality and Packaging AssuranceFavipiravir Tablets come securely packaged in boxes of 34 tablets to maintain product integrity and ensure safe delivery. The packaging is designed for easy distribution among exporters, suppliers, traders, and wholesalers, guaranteeing that the medication remains uncompromised throughout transit.
Proper Storage GuidelinesTo preserve the effectiveness of Favipiravir Tablets, always store them in a cool and dry place. Exposure to moisture or extreme temperatures can reduce their potency, making proper storage essential for maintaining their therapeutic benefits and safety.
FAQs of Favipiravir Tablets:
Q: How should Favipiravir Tablets be stored for maximum efficacy?
A: Favipiravir Tablets must be stored in a cool and dry place to protect them from moisture and heat, which can compromise their effectiveness.
Q: What is the recommended dosage for Favipiravir Tablets?
A: The dosage of Favipiravir Tablets should be determined by a physician and followed exactly as directed for safe and optimal results.
Q: When is the best time to take Favipiravir Tablets?
A: Favipiravir Tablets should be taken according to your healthcare providers instructions, ensuring consistent timing and adherence to the prescribed regimen.
Q: Where are Favipiravir Tablets manufactured?
A: These tablets originate from India, adhering to stringent pharmaceutical standards for quality and safety.
Q: What is the packaging quantity for Favipiravir Tablets?
A: Each box contains 34 tablets, packaged to maintain their quality and facilitate distribution among exporters, suppliers, traders, and wholesalers.
Q: Who can use Favipiravir Tablets, and are there any restrictions?
A: Favipiravir Tablets are suitable for all users as directed by the physician. Always consult your healthcare provider before use to confirm suitability and safety.
Q: What are the main benefits of Favipiravir Tablets?
A: Favipiravir Tablets are designed to manage viral infections efficiently, offering convenient packaging, broad suitability, and reliable storage guidelines to maximize their therapeutic potential.